Related Experiment Video
Updated: Feb 3, 2026

An Experimental Analysis of Children's Ability to Provide a False Report about a Crime
Published on: May 3, 2016
Use of baclofen in children with dysfunctional voiding: a preliminary report
Mehdi Shirazi1, Zahra Jahnabadi1, Pooya Hekmati1
1Shiraz University of Medical Sciences, Namazee Hospital, Department of Urology, Shiraz, Iran.
Insights
Baclofen effectively treats pediatric dysfunctional voiding (DV), significantly reducing symptoms like urgency and wetting. This study found baclofen safe and well-tolerated in children with DV.
Area of Science:
- Pediatric Urology
- Pharmacology
- Clinical Medicine
Background:
- Dysfunctional voiding (DV) is a common condition in children.
- Effective and safe treatment options for pediatric DV are needed.
Purpose of the Study:
- To evaluate the efficacy and safety of baclofen for treating pediatric dysfunctional voiding (DV).
Main Methods:
- Thirty children diagnosed with primary DV participated.
- Treatment involved oral baclofen (1 mg/kg/day in 3 doses) for 3 months.
- Assessments included uroflowmetry, post-void residual urine (PVRU) analysis, and the Dysfunctional Voiding Symptom Score (DVSS) questionnaire.
Main Results:
- Baclofen treatment led to a significant decrease in PVRU (mean 14.67 ml) and DVSS scores (mean 12.3).
- Key symptoms such as urgency, dysuria, and straining were significantly reduced.
- Improvements were noted in maximum flow rate (Qmax) and voluntary voiding episodes, with a reduction in wetting episodes.
Conclusions:
- Baclofen demonstrates potential as a safe and effective treatment for pediatric dysfunctional voiding.
- The medication was well-tolerated and associated with significant symptom improvement in children.
Introduction:
The aims of the present study were to examine the effectiveness and safety of baclofen in children with dysfunctional voiding (DV).
Material And Methods:
Thirty children with primary DV were enrolled. Patients underwent history taking, complete physical examination, urine analysis and culture, ultrasonography of the urinary system, a uroflowmetry study and post urine residue analysis. The Dysfunctional Voiding Symptom Score (DVSS) questionnaire was completed and other related symptoms were recorded. Oral baclofen was started for the study group at a dose of 1 mg/kg in 3 divided doses. Ultrasonography, a uroflowmetry study and questionnaire were repeated 3 months later.
Results:
We observed a mean decrease of 14.67 ml in post void residual urine (PVRU) after 3 months. After usage of baclofen, increase in Qmax (5.74), increase in mean flow rate (8.2 vs. 11.3), and an average decrease of 12.3 in the DVSS questionnaire (p <0.001) were also observed. The number of voluntary voiding and wetting episodes were significantly decreased after treatment with baclofen (p = 0.001). Three main complaints of the patients were urgency (p = 0.001), dysuria (p = 0.004) and straining (p = 0.004) and all were significantly decreased after medical therapy with baclofen.
Conclusions:
Baclofen may be useful in treatment of pediatric dysfunctional voiding. It was well tolerated among our patients with a remarkable reduction in their symptoms.
Related Concept Videos
Total Voids in Concrete
Imaging Studies VI: Voiding Cystourethrography and Cystography
Data Reporting and Recording
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Drug Dosing: Infants and Children

